» Articles » PMID: 2612116

Anticardiolipin Antibodies in Patients with Autoimmune Diseases: Isotype Distribution and Clinical Associations

Overview
Journal Clin Rheumatol
Publisher Springer
Specialty Rheumatology
Date 1989 Dec 1
PMID 2612116
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

A prospective study of IgG and IgM isotypes of anticardiolipin antibodies (aCL) was performed in a series of 167 patients with various autoimmune diseases, including rheumatic and nonrheumatic disorders, and in a group of 100 healthy blood donors. The IgG aCL serum was regarded as positive if a binding index (BI) greater than 2.85 (3.77 SD) was detected and a BI greater than 4.07 (3.90 SD) was defined as positive for IgM aCL. Forty patients (24%) were found to be positive for IgG and/or IgM aCL. IgG aCL were detected in 23% of patients with systemic lupus erythematosus (SLE), in 9% with idiopathic thrombocytopenic purpura, in 7% with progressive systemic sclerosis, and in 6% with dermatomyositis-polymyositis. IgM aCL were present in 43% patients with primary biliary cirrhosis, in 33% with rheumatoid arthritis, in 22% with SLE, and in 8% with giant-cell arteritis. IgG aCL were found to have a significant association with thrombosis and thrombocytopenia, and IgM and aCL with haemolytic anaemia and neutropenia, in SLE but not in the other autoimmune diseases. The identification of these differences in the aCL isotype associations, depending on the autoimmune disorder, may improve the clinical usefulness of these tests.

Citing Articles

Advantages and limitations of current diagnostic laboratory approaches in syphilis and congenital syphilis.

Cao W, Thorpe P, OCallaghan K, Kersh E Expert Rev Anti Infect Ther. 2023; 21(12):1339-1354.

PMID: 37934903 PMC: 10958575. DOI: 10.1080/14787210.2023.2280214.


Antiphospholipid Antibodies and Autoimmune Haemolytic Anaemia: A Systematic Review and Meta-Analysis.

Ames P, Merashli M, Bucci T, Pastori D, Pignatelli P, Arcaro A Int J Mol Sci. 2020; 21(11).

PMID: 32527000 PMC: 7313475. DOI: 10.3390/ijms21114120.


Clinical implications of elevated antiphospholipid antibodies in adult patients with primary immune thrombocytopenia.

Yang Y, Yun G, Song I, Baek S, Lee K, Ryu H Korean J Intern Med. 2011; 26(4):449-54.

PMID: 22205846 PMC: 3245394. DOI: 10.3904/kjim.2011.26.4.449.


The lung in the antiphospholipid syndrome.

Espinosa G, Cervera R, Font J, Asherson R Ann Rheum Dis. 2002; 61(3):195-8.

PMID: 11830421 PMC: 1754043. DOI: 10.1136/ard.61.3.195.


Increased thromboembolic incidence in anti-cardiolipin-positive patients with malignancy.

Zuckerman E, Toubi E, Golan T, Sabo E, Shmuel Z, Yeshurun D Br J Cancer. 1995; 72(2):447-51.

PMID: 7640230 PMC: 2034001. DOI: 10.1038/bjc.1995.353.


References
1.
Glueck H, Kant K, Weiss M, POLLAK V, Miller M, COOTS M . Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants. Arch Intern Med. 1985; 145(8):1389-95. View

2.
Sturfelt G, Nived O, NORBERG R, Thorstensson R, Krook K . Anticardiolipin antibodies in patients with systemic lupus erythematosus. Arthritis Rheum. 1987; 30(4):382-8. DOI: 10.1002/art.1780300404. View

3.
Bohan A, Peter J . Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975; 292(7):344-7. DOI: 10.1056/NEJM197502132920706. View

4.
Burns T, Saleem A . Idiopathic thrombocytopenic purpura. Am J Med. 1983; 75(6):1001-7. DOI: 10.1016/0002-9343(83)90881-1. View

5.
Asherson R, Harris E . Anticardiolipin antibodies--clinical associations. Postgrad Med J. 1986; 62(734):1081-7. PMC: 2418945. DOI: 10.1136/pgmj.62.734.1081. View